These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22786815)

  • 21. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
    Wang SJ; Hung HM; O'Neill R
    J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A unified method for monitoring and analysing controlled trials.
    Grossman J; Parmar MK; Spiegelhalter DJ; Freedman LS
    Stat Med; 1994 Sep; 13(18):1815-26. PubMed ID: 7997715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On efficient two-stage adaptive designs for clinical trials with sample size adjustment.
    Liu Q; Li G; Anderson KM; Lim P
    J Biopharm Stat; 2012; 22(4):617-40. PubMed ID: 22651105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative views on setting clinical trial futility criteria.
    Gallo P; Mao L; Shih VH
    J Biopharm Stat; 2014; 24(5):976-93. PubMed ID: 24933121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conditional estimation in two-stage adaptive designs.
    Broberg P; Miller F
    Biometrics; 2017 Sep; 73(3):895-904. PubMed ID: 28099993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of the binomial probabilities in a two-stage phase II clinical trial with two co-primary endpoints.
    Sun Y; Zhang X; Tan X; Tu D
    Contemp Clin Trials; 2021 Jun; 105():106390. PubMed ID: 33819639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of conditional bias-adjusted estimators for interim analysis in clinical trials with survival data.
    Shimura M; Gosho M; Hirakawa A
    Stat Med; 2017 Jun; 36(13):2067-2080. PubMed ID: 28211076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A free gift: an adaptive strategy in a single-arm trial using an exact test through the binomial distribution.
    Wang J
    J Biopharm Stat; 2012; 22(6):1127-36. PubMed ID: 23075012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-stage optimal designs based on exact variance for a single-arm trial with survival endpoints.
    Shan G
    J Biopharm Stat; 2020 Sep; 30(5):797-805. PubMed ID: 32129130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point estimation and p-values in phase II adaptive two-stage designs with a binary endpoint.
    Kunzmann K; Kieser M
    Stat Med; 2017 Mar; 36(6):971-984. PubMed ID: 28028823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On Two-stage Seamless Adaptive Design in Clinical Trials.
    Chow SC; Tu YH
    J Formos Med Assoc; 2008 Dec; 107(12 Suppl):52-60. PubMed ID: 19129046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generalizing boundaries for triangular designs, and efficacy estimation at extended follow-ups.
    Allison A; Edwards T; Omollo R; Alves F; Magirr D; E Alexander ND
    Trials; 2015 Nov; 16():522. PubMed ID: 26573827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal multistage designs for randomised clinical trials with continuous outcomes.
    Wason JM; Mander AP; Thompson SG
    Stat Med; 2012 Feb; 31(4):301-12. PubMed ID: 22139822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Planning and analyzing adaptive group sequential survival trials.
    Wassmer G
    Biom J; 2006 Aug; 48(4):714-29. PubMed ID: 16972724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unbiased estimation for response adaptive clinical trials.
    Bowden J; Trippa L
    Stat Methods Med Res; 2017 Oct; 26(5):2376-2388. PubMed ID: 26265771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.